Kevin Meesters
banner
meestersmd.bsky.social
Kevin Meesters
@meestersmd.bsky.social
Pediatrician – ID physician 🧫 | MD MPH PhD | 🇳🇱🇧🇪🇬🇧🇨🇦 trained | Passionate about AMS, clin pharm, adolescent health, TxID & MedEd | 🌈 in medicine | Views my own

YVR, #beautifulbc, Canada 🍁
Agree- S aureus infections 🦠 can be very complex, but a median IV duration of 24.5 days seems way too long
June 10, 2025 at 7:53 AM
Still, this study adds to evidence supporting daptomycin doses of 10 mg/kg/day or even higher, and worth further study.

But it also underscores the ongoing need for antimicrobial stewardship in complex pediatric infections.
June 9, 2025 at 4:10 PM
Several combos raise (my) eyebrows:

🧪 teicoplanin + amox-clav + vancomycin + cefazolin
🧪 amox-clav + rifampin + amikacin

❗Even in what is most likely mono-bacterial!

This reflects a broader issue: indication creep and layering of MRSA agents without clear rationale. #AMS
June 9, 2025 at 4:10 PM
🔸 All patients were on other antibiotics with daptomycin.

🔸 10/12 MSSA cases got cefazolin concurrently—so why add dapto at all?

🔸 After IV, many continued dual oral staph coverage (e.g., amox-clav + TMP/SMX).

Hard to isolate what worked.

#AntimicrobialStewardship
#AMR
#microsky
June 9, 2025 at 4:10 PM
💉 High-dose daptomycin (~10 mg/kg/day) was used in >50%, with clinical success in 90%, major CRP reductions, and no serious adverse events.

Median duration: 24.5 days IV
Many transitioned to oral step-down.

Sounds promising—until you look closer.
June 9, 2025 at 4:10 PM